课题基金 / 基金详情

National HIV Behavioral Surveillance System

National HIV Behavioral Surveillance System
国家艾滋病毒行为监测系统
批准号:
8119922
负责人:
TOM JAENICKE
金额:
$47.33万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31

项目摘要

项目成果

TOM JAENICKE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):美国疾病控制与预防中心(CDC)目前在美国21个大都市统计区(MSA)开展国家艾滋病毒行为监测(NHBS),包括西雅图MSA。我们建议从2011年到2015年在西雅图MSA继续实施NHBS。NHBS在西雅图MSA的目标是为当地HIV预防资源分配和预防项目评估提供相关数据。为了实现这一目标,我们建议与CDC合作,继续维护和评估与男男性行为者(MSM)、注射吸毒者(IDU)和高危异性恋者(HET)中与HIV感染相关的行为和合并感染的监测系统。具体而言,我们将每年进行形成性研究、社区调查和艾滋病毒检测。我们将每年进行一次调查,评估西雅图地区MSM(2011年和2014年)、IDU(2012年和2015年)和HET(2014年)的艾滋病毒风险行为、艾滋病毒预防服务的获取和利用以及艾滋病毒感染率。我们将与西雅图地区的社区组织、公共卫生部门的同事、华盛顿大学在定性和定量方法方面具有专业知识的研究人员合作,开展NHBS,并评估和传播结果。我们将采用基于场所的时空抽样(VBS)和受访者驱动抽样(RDS),并在MSM和IDU周期和HET周期中分别对500名符合条件的参与者进行调查。我们将为所有三个周期的NHBS参与者提供自愿艾滋病毒咨询和检测,以评估艾滋病毒血清阳性率。我们将对NHBS系统进行评估,包括抽样策略和数据收集方法,以确保系统达到其目标,并为提高地方和全国NHBS的质量、效率和实用性提供建议。我们将与西雅图地区社区组织合作开发和实施当地预防调查问题,这些组织由疾病预防控制中心直接资助,或通过社区规划过程由州或地方资金资助。我们将促进国家数据收集成果,如MMWR报告和其他出版物,并提供数据传播计划,以促进地方和国家监测报告工作。最后,我们将在MSM和IDU周期中实施丙型肝炎咨询和检测,以评估丙型肝炎血清阳性率。西雅图地区的NHBS系统将继续以西雅图和金县公共卫生艾滋病毒/性病项目为基础。
英文摘要
DESCRIPTION (provided by applicant): The Centers for Disease Control and Prevention (CDC) currently conducts National HIV Behavioral Surveillance (NHBS) in 21 metropolitan statistical areas (MSA) in the U.S., including the Seattle MSA. We propose to continue NHBS in the Seattle MSA from 2011 to 2015. The goal of NHBS in the Seattle MSA is to provide relevant data for local HIV prevention resource allocation and prevention program evaluation. To accomplish this goal, we propose to collaborate with CDC to continue maintaining and evaluating a surveillance system of behaviors and co-infections related to HIV acquisition in men who have sex with men (MSM), injection drug users (IDU), and heterosexuals at increased risk (HET). Specifically, we will conduct formative research and community-based surveys and HIV testing each year. We will conduct a survey each year to assess HIV risk behaviors, HIV prevention services access and utilization, and HIV prevalence among Seattle-area MSM (2011 and 2014), IDU (2012 and 2015) and HET (2014). We will collaborate with Seattle area community-based organizations, public health department colleagues, University of Washington researchers with expertise in qualitative and quantitative methods to conduct NHBS and evaluate and disseminate results. We will employ venue-based time-space sampling (VBS) and respondent-driven sampling (RDS) and complete surveys with 500 eligible participants in each of the MSM and IDU cycles and 450 in the HET cycle. We will provide voluntary HIV counseling and testing to NHBS participants in all three cycles to assess HIV seroprevalence. We will conduct evaluations of the NHBS system including sampling strategies, and data collection methods to ensure that the system meets its goals, and provide recommendations for improving the quality, efficiency and usefulness of NHBS both locally and nationally. We will collaborate on development and implementation of local prevention survey questions with Seattle area community-based organizations that are directly funded by CDC or funded by state or local funding through the community planning process. We will contribute to the national data collections outcomes such as MMWR reports and other publications, and provide a data dissemination plan that will contribute to local and national surveillance reporting efforts. Finally, we will implement hepatitis C counseling and testing in the MSM and IDU cycles to assess hepatitis C seroprevalence. The Seattle area NHBS system will continue to be based at the HIV/STD Program of Public Health - Seattle & King County.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
National HIV Surveillance System
National HIV Surveillance System
National HIV Behavioral Surveillance System
National HIV Behavioral Surveillance System
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究